 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hormone/growth factor
|
PDB id
|
|
|
|
1nk1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hormone/growth factor
|
 |
|
Title:
|
 |
Nk1 fragment of human hepatocyte growth factor/scatter factor (hgf/sf) at 2.5 angstrom resolution
|
|
Structure:
|
 |
Protein (hepatocyte growth factor precursor). Chain: a, b. Fragment: nk1. Synonym: scatter factor, sf, hepatopoeitin a. Engineered: yes. Mutation: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Cell_line: mrc5. Organ: lung. Cell: fibroblast. Cellular_location: extracellular. Gene: hepatocyte growth factor/scatter factor. Expressed in: pichia pastoris.
|
|
Biol. unit:
|
 |
Dimer (from
)
|
|
Resolution:
|
 |
|
2.50Å
|
R-factor:
|
0.245
|
R-free:
|
0.319
|
|
|
Authors:
|
 |
D.Y.Chirgadze,J.P.Hepple,H.Zhou,R.A.Byrd,T.L.Blundell, E.Gherardi
|
Key ref:
|
 |
D.Y.Chirgadze
et al.
(1999).
Crystal structure of the NK1 fragment of HGF/SF suggests a novel mode for growth factor dimerization and receptor binding.
Nat Struct Biol,
6,
72-79.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
20-Aug-98
|
Release date:
|
13-Jan-99
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
|
|
P14210
(HGF_HUMAN) -
Hepatocyte growth factor
|
|
|
|
Seq: Struc:
|
 |
 |
 |
728 a.a.
172 a.a.
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Nat Struct Biol
6:72-79
(1999)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of the NK1 fragment of HGF/SF suggests a novel mode for growth factor dimerization and receptor binding.
|
|
D.Y.Chirgadze,
J.P.Hepple,
H.Zhou,
R.A.Byrd,
T.L.Blundell,
E.Gherardi.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Although ligand-induced receptor dimerization is a common prerequisite for
receptor activation, the mode by which different growth factors bind their
receptors and cause them to dimerize varies considerably. Here we report the
crystal structure at 2.5 A resolution of NK1, a receptor-binding fragment and a
natural splice variant of hepatocyte growth factor/scatter factor (HGF/SF). NK1
assembles as a homodimer in the asymmetric unit, revealing a novel mode of
growth factor dimerization produced by close packing of the N domain of one
subunit and the kringle domain of the other, thus bringing the two linkers in
close proximity. The structure suggests the presence of a binding site for
heparan sulfate chains and a mechanism by which the NK1 dimer may engage two
receptor molecules through clusters of amino acids located on each protomer and
on opposite surfaces of the homodimer. We also report that short (14-mer)
heparin fragments effectively dimerize NK1 in solution, implying that heparan
sulfate chains may stabilize the NK1 dimer. These results provide a basis for
the agonistic activity of NK1 and have implications for the mechanism of
receptor binding of HGF/SF.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. Schematic representation of the domain structure of
HGF/SF. The N-terminal (N) domain is shown as a triangle, the
kringle (K) domains are shown as circles and the catalytically
inactive serine proteinase domain as a rectangle. Also shown is
the location of the trypsinlike site between the C-terminal
kringle and the serine proteinase domain that is cleaved during
activation of pro-HGF/SF. The lines with arrows below the figure
indicate the domain composition of the NK1 and NK2 fragments of
HGF/SF.
|
 |
Figure 2.
Figure 2. a, Ribbon representation of the NK1 homodimer observed
in the crystal's asymmetric unit. The view is along a
non-crystallographic two-fold axis. Protomers A and B are shown
in blue and green, respectively. The N and kringle domains of
each protomer are labeled as N and K. The disulfide bridges are
shown in yellow. The linker (residues Lys 122−Asn 127) of each
protomer is shown in magenta for protomer A and orange for
protomer B. b, Side view of the NK1 homodimer shown in (a) (same
color coding). Protomer B (green) is located behind protomer A
(blue). The amino- and carboxy-termini are labeled. The figure
was generated with SETOR^50.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Macmillan Publishers Ltd:
Nat Struct Biol
(1999,
6,
72-79)
copyright 1999.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
T.Nakamura,
K.Sakai,
T.Nakamura,
and
K.Matsumoto
(2011).
Hepatocyte growth factor twenty years on: Much more than a growth factor.
|
| |
J Gastroenterol Hepatol, 26,
188-202.
|
 |
|
|
|
|
 |
K.A.Owen,
D.Qiu,
J.Alves,
A.M.Schumacher,
L.M.Kilpatrick,
J.Li,
J.L.Harris,
and
V.Ellis
(2010).
Pericellular activation of hepatocyte growth factor by the transmembrane serine proteases matriptase and hepsin, but not by the membrane-associated protease uPA.
|
| |
Biochem J, 426,
219-228.
|
 |
|
|
|
|
 |
R.Sinha Roy,
S.Soni,
R.Harfouche,
P.R.Vasudevan,
O.Holmes,
H.de Jonge,
A.Rowe,
A.Paraskar,
D.M.Hentschel,
D.Chirgadze,
T.L.Blundell,
E.Gherardi,
R.A.Mashelkar,
and
S.Sengupta
(2010).
Coupling growth-factor engineering with nanotechnology for therapeutic angiogenesis.
|
| |
Proc Natl Acad Sci U S A, 107,
13608-13613.
|
 |
|
|
|
|
 |
W.D.Tolbert,
J.Daugherty-Holtrop,
E.Gherardi,
G.Vande Woude,
and
H.E.Xu
(2010).
Structural basis for agonism and antagonism of hepatocyte growth factor.
|
| |
Proc Natl Acad Sci U S A, 107,
13264-13269.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.A.Deakin,
B.S.Blaum,
J.T.Gallagher,
D.Uhrín,
and
M.Lyon
(2009).
The Binding Properties of Minimal Oligosaccharides Reveal a Common Heparan Sulfate/Dermatan Sulfate-binding Site in Hepatocyte Growth Factor/Scatter Factor That Can Accommodate a Wide Variety of Sulfation Patterns.
|
| |
J Biol Chem, 284,
6311-6321.
|
 |
|
|
|
|
 |
J.M.Schultz,
S.N.Khan,
Z.M.Ahmed,
S.Riazuddin,
A.M.Waryah,
D.Chhatre,
M.F.Starost,
B.Ploplis,
S.Buckley,
D.Velásquez,
M.Kabra,
K.Lee,
M.J.Hassan,
G.Ali,
M.Ansar,
M.Ghosh,
E.R.Wilcox,
W.Ahmad,
G.Merlino,
S.M.Leal,
S.Riazuddin,
T.B.Friedman,
and
R.J.Morell
(2009).
Noncoding mutations of HGF are associated with nonsyndromic hearing loss, DFNB39.
|
| |
Am J Hum Genet, 85,
25-39.
|
 |
|
|
|
|
 |
K.R.Catlow,
J.A.Deakin,
Z.Wei,
M.Delehedde,
D.G.Fernig,
E.Gherardi,
J.T.Gallagher,
M.S.Pavão,
and
M.Lyon
(2008).
Interactions of hepatocyte growth factor/scatter factor with various glycosaminoglycans reveal an important interplay between the presence of iduronate and sulfate density.
|
| |
J Biol Chem, 283,
5235-5248.
|
 |
|
|
|
|
 |
V.V.Stepanova,
I.B.Beloglazova,
Y.G.Gursky,
R.S.Bibilashvily,
Y.V.Parfyonova,
and
V.A.Tkachuk
(2008).
Interaction between kringle and growth-factor-like domains in the urokinase molecule: possible role in stimulation of chemotaxis.
|
| |
Biochemistry (Mosc), 73,
252-260.
|
 |
|
|
|
|
 |
W.D.Tolbert,
J.Daugherty,
C.Gao,
Q.Xie,
C.Miranti,
E.Gherardi,
G.V.Woude,
and
H.E.Xu
(2007).
A mechanistic basis for converting a receptor tyrosine kinase agonist to an antagonist.
|
| |
Proc Natl Acad Sci U S A, 104,
14592-14597.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
E.Gherardi,
S.Sandin,
M.V.Petoukhov,
J.Finch,
M.E.Youles,
L.G.Ofverstedt,
R.N.Miguel,
T.L.Blundell,
G.F.Vande Woude,
U.Skoglund,
and
D.I.Svergun
(2006).
Structural basis of hepatocyte growth factor/scatter factor and MET signalling.
|
| |
Proc Natl Acad Sci U S A, 103,
4046-4051.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.Pizarro-Cerdá,
and
P.Cossart
(2006).
Subversion of cellular functions by Listeria monocytogenes.
|
| |
J Pathol, 208,
215-223.
|
 |
|
|
|
|
 |
L.J.de Koning,
P.T.Kasper,
J.W.Back,
M.A.Nessen,
F.Vanrobaeys,
J.Van Beeumen,
E.Gherardi,
C.G.de Koster,
and
L.de Jong
(2006).
Computer-assisted mass spectrometric analysis of naturally occurring and artificially introduced cross-links in proteins and protein complexes.
|
| |
FEBS J, 273,
281-291.
|
 |
|
|
|
|
 |
M.Banerjee,
J.Copp,
D.Vuga,
M.Marino,
T.Chapman,
P.van der Geer,
and
P.Ghosh
(2004).
GW domains of the Listeria monocytogenes invasion protein InlB are required for potentiation of Met activation.
|
| |
Mol Microbiol, 52,
257-271.
|
 |
|
|
|
|
 |
M.Lyon,
J.A.Deakin,
D.Lietha,
E.Gherardi,
and
J.T.Gallagher
(2004).
The interactions of hepatocyte growth factor/scatter factor and its NK1 and NK2 variants with glycosaminoglycans using a modified gel mobility shift assay. Elucidation of the minimal size of binding and activatory oligosaccharides.
|
| |
J Biol Chem, 279,
43560-43567.
|
 |
|
|
|
|
 |
T.G.Wright,
J.Tsai,
Z.Jia,
and
B.E.Elliott
(2004).
Inhibition by copper(II) binding of hepatocyte growth factor (HGF) interaction with its receptor Met and blockade of HGF/Met function.
|
| |
J Biol Chem, 279,
32499-32506.
|
 |
|
|
|
|
 |
J.T.Douglas,
P.D.von Haller,
M.Gehrmann,
M.Llinás,
and
J.Schaller
(2002).
The two-domain NK1 fragment of plasminogen: folding, ligand binding, and thermal stability profile.
|
| |
Biochemistry, 41,
3302-3310.
|
 |
|
|
|
|
 |
M.Delehedde,
M.Lyon,
R.Vidyasagar,
T.J.McDonnell,
and
D.G.Fernig
(2002).
Hepatocyte growth factor/scatter factor binds to small heparin-derived oligosaccharides and stimulates the proliferation of human HaCaT keratinocytes.
|
| |
J Biol Chem, 277,
12456-12462.
|
 |
|
|
|
|
 |
P.Pediaditakis,
S.P.Monga,
W.M.Mars,
and
G.K.Michalopoulos
(2002).
Differential mitogenic effects of single chain hepatocyte growth factor (HGF)/scatter factor and HGF/NK1 following cleavage by factor Xa.
|
| |
J Biol Chem, 277,
14109-14115.
|
 |
|
|
|
|
 |
C.J.Kuo,
K.R.LaMontagne,
G.Garcia-Cardeña,
B.D.Ackley,
D.Kalman,
S.Park,
R.Christofferson,
J.Kamihara,
Y.H.Ding,
K.M.Lo,
S.Gillies,
J.Folkman,
R.C.Mulligan,
and
K.Javaherian
(2001).
Oligomerization-dependent regulation of motility and morphogenesis by the collagen XVIII NC1/endostatin domain.
|
| |
J Cell Biol, 152,
1233-1246.
|
 |
|
|
|
|
 |
D.Lietha,
D.Y.Chirgadze,
B.Mulloy,
T.L.Blundell,
and
E.Gherardi
(2001).
Crystal structures of NK1-heparin complexes reveal the basis for NK1 activity and enable engineering of potent agonists of the MET receptor.
|
| |
EMBO J, 20,
5543-5555.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.T.Gallagher
(2001).
Heparan sulfate: growth control with a restricted sequence menu.
|
| |
J Clin Invest, 108,
357-361.
|
 |
|
|
|
|
 |
S.Tumova,
A.Woods,
and
J.R.Couchman
(2000).
Heparan sulfate proteoglycans on the cell surface: versatile coordinators of cellular functions.
|
| |
Int J Biochem Cell Biol, 32,
269-288.
|
 |
|
|
|
|
 |
T.L.Blundell,
D.F.Burke,
D.Chirgadze,
V.Dhanaraj,
M.Hyvönen,
C.A.Innis,
E.Parisini,
L.Pellegrini,
M.Sayed,
and
B.L.Sibanda
(2000).
Protein-protein interactions in receptor activation and intracellular signalling.
|
| |
Biol Chem, 381,
955-959.
|
 |
|
|
|
|
 |
T.Otsuka,
J.Jakubczak,
W.Vieira,
D.P.Bottaro,
D.Breckenridge,
W.J.Larochelle,
and
G.Merlino
(2000).
Disassociation of met-mediated biological responses in vivo: the natural hepatocyte growth factor/scatter factor splice variant NK2 antagonizes growth but facilitates metastasis.
|
| |
Mol Cell Biol, 20,
2055-2065.
|
 |
|
|
|
|
 |
Y.Shen,
M.Naujokas,
M.Park,
and
K.Ireton
(2000).
InIB-dependent internalization of Listeria is mediated by the Met receptor tyrosine kinase.
|
| |
Cell, 103,
501-510.
|
 |
|
|
|
|
 |
Y.W.Chen,
E.J.Dodson,
and
G.J.Kleywegt
(2000).
Does NMR mean "not for molecular replacement"? Using NMR-based search models to solve protein crystal structures.
|
| |
Structure, 8,
R213-R220.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|